# Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC

> **NCT00997906** · PHASE2,PHASE3 · UNKNOWN · sponsor: **National Cancer Centre, Singapore** · enrollment: 172 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** carboplatin,
- **DRUG:** cisplatin
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** paclitaxel
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT00997906
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-09-15
- **Primary completion:** 2017-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2022-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997906, "Cisplatin and RT With or Without Gemcitabine, Carboplatin, and Paclitaxel in Treating Patients With Locally Advanced NPC". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00997906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*